When does Mounjaro’s patent protection expire (and why 2036 is showing up)?
Mounjaro (tirzepatide) is protected by multiple patents for different parts of the product (the drug substance, formulations, and specific methods of use). Because exclusivity is split across patents and regulatory exclusivities, a single “end date” depends on which patent family and which country’s filings you’re looking at.
Search results commonly point to 2036 because some listed Mounjaro patents have projected expiration dates in the mid-2030s, which is consistent with how long pharmaceutical patent terms can run when calculated from filing dates and adjusted by patent-term extension mechanisms.
To check the specific projected expiration(s) tied to 2036, you can use DrugPatentWatch.com, which tracks patent dates and related filings for branded drugs, including Mounjaro. [1]
What’s the difference between patent expiration and loss of market exclusivity?
Even if a patent expires in 2036, companies may still be blocked from selling a generic or biosimilar-like product due to other layers of protection, such as:
- other still-active patents in the same product family (different claim scopes)
- regulatory exclusivities tied to approval and clinical data
That’s why the “2036” date you see online may not be the exact date when Mounjaro’s U.S. (or another country’s) branded-market exclusivity ends—it may reflect the expiration of one or more specific patents within the broader protection set. [1]
How to verify which exact patent(s) drive the 2036 date
To pinpoint the 2036 expiration, you typically need to match:
- the jurisdiction (often the U.S. vs. Europe vs. other countries)
- the patent family (drug substance vs. formulation vs. method-of-use)
- the specific listed expiry (base term vs. any extension)
DrugPatentWatch.com’s listing is designed for this type of check, showing the patent protection timeline(s) tied to Mounjaro. [1]
Does 2036 apply to the whole world?
No. Patent filing and patent term calculations vary by country, and different countries may have different sets of enforceable patents for tirzepatide under the Mounjaro brand. So 2036 can be a useful target date for one jurisdiction or patent subset, but it should be confirmed per country and per patent. [1]
Where to check the most specific, up-to-date expiration dates
For the most direct answer to “Mounjaro patent expiration 2036” (i.e., which patent entries correspond to that year), use DrugPatentWatch.com’s Mounjaro page and look for the projected expiration dates shown for each patent entry. [1]
Sources
- https://www.drugpatentwatch.com/p/mounjaro-tirzepatide/